ESC 2024：详细日程一览！4部新指南、37项Hot Line研究即将重磅发布！
时间：2024-08-01 16:00:16 热度：37.1℃ 作者：网络
2024 ESC Guidelines HOT LINE 1
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
2024 ESC高血压和高血压管理指南2024 ESC Guidelines for the Management of Chronic Coronary Syndromes
2024 ESC慢性冠状动脉综合征管理指南2024 ESC Guidelines for the Management of Atrial Fibrillation
2024 ESC心房颤动管理指南2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases
2024 ESC外周动脉和主动脉疾病管理指南HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
HELIOS-B研究——Vutrisiran治疗转甲状腺素蛋白淀粉样变心肌病患者3期研究的主要结果
Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control
既往心肌梗死患者中断使用β受体阻滞剂：ABYSS试验结果及其对血压和心率控制的影响
STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial
STOP-or-NOT研究——肾素-血管紧张素系统抑制剂持续与停用对术后并发症的影响：一项多中心随机对照试验
HOT LINE 2
The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity
BedMed和BedMed Frail随机对照试验——降压时间对死亡率和发病率的影响
Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail
降压药物睡前给药试验的荟萃分析，包括来自BedMed和BedMed Frail试验的个体患者数据
GMRx2 - Efficacy and safety of a novel triple single pill combination
新型三药单片复方制剂GMRx2的有效性和安全性
QUADRO - A single 4-drug combination in hypertension
QUADRO——单片四药联合治疗在高血压患者中的应用
VERONICA-Nigeria - deliVERy of Optimal blood pressure coNtrol in afrICA
VERONICA-Nigeria研究——在非洲提供最佳血压控制
HOT LINE 3
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
RESHAPE-HF2研究——经皮修复症状性心力衰竭患者中重度或重度功能性二尖瓣反流
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
MATTERHORN研究——经导管 vs. 外科二尖瓣修复术治疗心力衰竭合并继发性二尖瓣反流
Tri.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation
TRI.FR试验——经导管缘对缘修复术治疗严重孤立性继发性三尖瓣反流的多中心随机评价
HOT LINE 4
ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery
ASSURE DES研究——非心脏手术前冠状动脉支架患者的围手术期抗血小板治疗
SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting
SWEDEGRAFT研究——不接触获取静脉移植物技术在冠状动脉搭桥术中的应用
The TIGHT-K trial - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery
TIGHT-K试验——心脏手术后补充钾与房颤的预防
HOT LINE 5
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
NOTION-3研究——TAVI患者的PCI治疗
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
POPULAL PAUSE TAVI研究——TAVI期间继续或中断口服抗凝治疗？
RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis
RHEIA研究——女性重度主动脉狭窄患者经导管 vs. 外科主动脉瓣置换术治疗
HOT LINE 6
STEEER-AF - Stroke prevention and rhythm control therapy
STEEER-AF研究——卒中预防和节律控制治疗
OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation
OCEANIC-AF研究——Asundexian vs. 阿哌沙班治疗心房颤动
EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary arthery disease
EPIC-CAD研究——艾多沙班单药 vs. 双联抗血栓治疗心房颤动合并稳定型冠状动脉疾病
HOT LINE 7
FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction
FINEARTS-HF研究——非奈利酮在射血分数轻度降低和保留型心力衰竭患者中的应用
MRAs in heart failure - An individual patient data meta-analysis of randomised trials
心力衰竭的MRAs——随机试验的个体患者数据荟萃分析
FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials
FINE-HEART研究——非奈利酮在心力衰竭和慢性肾脏病试验中的参与者水平汇总分析
HOT LINE 8
SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial
SENIOR RITA研究——老年非ST段抬高型心肌梗死患者随机介入治疗试验
EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients
EARTH-STEMI研究——老年STEMI患者完全血运重建 vs. 仅罪犯血管血运重建
SCOFF - Fasting or no fasting before cardiac catherisation procedures
SCOFF研究——心脏导管术前禁食或不禁食
HOT LINE 9
STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds
STROKESTOP II研究——75岁人群中随机系统性NT-proBNP和心电图筛查心房颤动
GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals
GUARD-AF研究——通过筛查未确诊的老年人心房颤动来减少卒中
MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China
MIRACLE-AF研究——中国农村老年心房颤动患者的综合护理新模式
HOT LINE 10
SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation
SHAM-PVI研究——症状性心房颤动患者肺静脉隔离的随机假对照研究
SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation
SUPPRESS-AF研究——低电压区域消融治疗持续性心房颤动患者房性快速性心律失常复发的疗效
HOT LINE 11
OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions
OCCUPI研究——OCT引导下复杂病变的冠状动脉介入治疗
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
INFINITY-SWEDEHEART研究——生物适配器与当代药物洗脱支架PCI的比较：一年主要结果
REC-CAGEFREE I - A noninferiority study of drug-coated balloon vs drug-eluting stent for de novo coronary artery lesions
REC-CAGEFREE I研究——药物涂层球囊 vs. 药物洗脱支架治疗冠脉De Novo病变的非劣效性研究
HOT LINE 12
